Description
DIASORIN REAGENTS AND CONSUMABLES
First action · last action
2020-04-21 · 2022-05-12
Transactions
6
First transaction's obligation
$148,832
Base + all options value (sum of deltas)
$225,508
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Modification chain · 6 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2020-04-21+$148,832= $148,832
- Mod P000012020-04-29+$0= $148,832
- Mod P000022020-10-09+$47,328= $196,160
- Mod P000032020-10-13+$0= $196,160
- Mod P000042020-12-08+$30,000= $226,160
- Mod P000052022-05-12-$652= $225,508
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2020-04-21 | +$148,832 | $148,832 | DIASORIN REAGENTS AND CONSUMABLES |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2020-04-29 | +$0 | $148,832 | DIASORIN REAGENTS AND CONSUMABLES |
| Mod P00002· FUNDING ONLY ACTION | 2020-10-09 | +$47,328 | $196,160 | DIASORIN REAGENTS AND CONSUMABLES |
| Mod P00003· OTHER ADMINISTRATIVE ACTION | 2020-10-13 | +$0 | $196,160 | DIASORIN REAGENTS AND CONSUMABLES |
| Mod P00004· FUNDING ONLY ACTION | 2020-12-08 | +$30,000 | $226,160 | DIASORIN REAGENTS AND CONSUMABLES |
| Mod P00005· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2022-05-12 | −$652 | $225,508 | DIASORIN REAGENTS AND CONSUMABLES |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI KFFNMC55GHS5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25026P0698 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $40,000 | FY2026 |
| 36C24126N0536 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $149,900 | FY2026 |
| 36C24126A0031 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2026 |
| 36C25026D0011 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $0 | FY2026 |
| 36C25026N0070 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $68,420 | FY2026 |
| 36C26326N0099 | NETWORK CONTRACT OFFICE 23 (36C263) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $19,500 | FY2026 |
Other recipients under 6640 from 241-NETWORK CONTRACT OFFICE 01 (36C241) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24126P0510 | CYTEK BIOSCIENCES, INC. | 241-NETWORK CONTRACT OFFICE 01 (36C241) | $531,939 | FY2026 |
| 36C24126F0116 | FISHER SCIENTIFIC COMPANY L.L.C. | 241-NETWORK CONTRACT OFFICE 01 (36C241) | $51,256 | FY2026 |
| 36C24126N0682 | WERFEN USA LLC | 241-NETWORK CONTRACT OFFICE 01 (36C241) | $48,410 | FY2026 |
| 36C24126N0717 | WERFEN USA LLC | 241-NETWORK CONTRACT OFFICE 01 (36C241) | $67,510 | FY2026 |
| 36C24126N0665 | WERFEN USA LLC | 241-NETWORK CONTRACT OFFICE 01 (36C241) | $66,505 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24120P0588_3600_-NONE-_-NONE- · retrieved 2026-09-26.